X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.news-medical.net/news/20210816/Experimental-drug-and-immunotherapy-combination-shows-promise-in-bladder-cancer-study.aspx
https://www.fiercebiotech.com/biotech/xynomic-preps-broad-push-for-hdac-cancer-drug-after-series-b
https://www.fiercebiotech.com/biotech/despite-asco-wobble-syndax-pals-up-nektar-entinostat-combo-trial
https://endpts.com/syndax-is-hit-with-a-setback-during-the-asco-preview-round-as-lead-drug-flops-in-mid-stage-study/
http://www.fiercebiotech.com/story/syndax-adds-genentech-pd-l1-atezo-combo-pact-its-growing-pipeline/2015-08-27
http://www.fiercebiotech.com/story/merck-ties-tiny-syndax-breakthrough-cancer-combo/2015-03-31
http://www.reuters.com/article/2015/04/01/roche-cancer-idUSL6N0WY1OB20150401
https://www.pmlive.com/pharma_news/merck_adds_another_immuno-oncology_tie-up_698622
Market Place
Share 
